Company Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal.
The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration.
It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels.
The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018.
Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 10, 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 570 |
| CEO | Ronald Lombardi |
Contact Details
Address: 660 White Plains Road, Suite 250 Tarrytown, New York 10591 United States | |
| Phone | 914 524 6800 |
| Website | prestigebrands.com |
Stock Details
| Ticker Symbol | PBH |
| Exchange | NYSE |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001295947 |
| CUSIP Number | 74112D101 |
| ISIN Number | US74112D1019 |
| Employer ID | 20-1297589 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ronald M. Lombardi CPA | Chairman, President and Chief Executive Officer |
| Christine Sacco CPA | Chief Financial Officer |
| Jeffrey Zerillo | Senior Vice President of Operations |
| William C. P'Pool J.D. | Senior Vice President, General Counsel and Corporate Secretary |
| Adel Mekhail | Executive Vice President of Marketing and Sales |
| Philip David Terpolilli C.F.A. | Director of Investor Relations |
| Dean Siegal | Director of Communications |
| Mary Beth Fritz | Senior Vice President of Quality and Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2024 | 144 | Filing |
| Nov 18, 2024 | 144 | Filing |
| Nov 12, 2024 | 144 | Filing |
| Nov 12, 2024 | 144 | Filing |
| Nov 12, 2024 | 144 | Filing |
| Nov 12, 2024 | 144 | Filing |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Nov 7, 2024 | 8-K | Current Report |
| Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |